Tirzepatide monograph · Evidence review
Missed a Tirzepatide Dose? The FDA 4-Day Rule, Explained
Missed your weekly Zepbound or Mounjaro shot? The FDA label rule: take it within 4 days (96 hours), skip it if more time has passed, and never double up.
Researched & written by Alan Pierce · last updated
Clinical Pharmacology Writer
It happens to almost everyone on a weekly injection eventually: the day comes and goes, and you realize you forgot your shot. With tirzepatide — sold as Zepbound for weight management and Mounjaro for type 2 diabetes — there is a clear, official rule for exactly this situation, and it removes the guesswork. The FDA prescribing information spells out what to do, and the single most important thing to know is that you should never take two doses to "catch up."
This is general education tied to the FDA label, not personal medical advice. The patient Instructions for Use in your box and your prescriber are the final word for your situation1.
The 4-day rule, straight from the label
The Zepbound prescribing information states it plainly: if a dose is missed, administer it as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take the next dose on your regularly scheduled day1. The Mounjaro label carries the same once-weekly drug, and the same titration framework2.
In other words, the deadline is four days. Inside that window, take it and carry on. Outside it, let it go and resume your normal weekly rhythm — you do not restart the schedule or change anything else.
§ Missed Dose — FDA Prescribing Information
Missed your weekly dose
How many days have passed?
≤ 4 days (96 h): take it now
Then resume your normal weekly schedule
> 4 days: skip it
Take the next dose on your scheduled day
Never double up
Keep ≥72 h between any two doses
After you take a late dose: resetting your weekly day
There's a wrinkle people miss. If you take a forgotten dose a few days late, your "anchor day" may shift, and the label has a guardrail for that too. The Zepbound label allows you to change the day of weekly administration if necessary, as long as at least 3 days (72 hours) separate two doses1.
So if your normal day is Sunday, you forgot, and you take it on Tuesday (within the 4-day window), you now have a choice. You can either keep injecting on Tuesdays going forward, or move back toward Sunday — but only if your next Sunday shot would still be at least 72 hours after that Tuesday dose. The 72-hour floor exists to stop two doses from landing too close together. When in doubt, the simpler path is to make the new day your day, since any consistent weekly day is fine. (For why no day or hour is pharmacologically "better," see the best time and day to inject tirzepatide.)
The rule that matters most: never double up
The one mistake to avoid is taking two doses close together to make up for a missed one. The label's missed-dose instruction is to take the single missed dose within the window or skip it — not to add it on top of your next scheduled dose1. Doubling up is what the 72-hour minimum-spacing rule is designed to prevent.
Why does this matter so much? Tirzepatide's side effects are dose-dependent, and the gastrointestinal effects — nausea, vomiting, diarrhea — are most pronounced when blood levels of the drug rise34. Stacking two doses too close together effectively spikes your exposure and can provoke exactly the severe GI symptoms the slow, four-week titration schedule is built to avoid3. There is no benefit to "catching up" on lost drug, and a real risk of making yourself sick. One missed weekly dose of a long-acting drug is not a crisis; an accidental double dose can be.
§ Key Rules at a Glance
Tirzepatide missed-dose rules
- Within 4 days (96 hours): take the missed dose, then continue as normal.
- More than 4 days late: skip it and take the next dose on schedule.
- Never take two doses together to make up for a missed one.
- Keep at least 72 hours between any two doses if you shift your day.
- One missed week is a small dip, not a crisis — the drug's ~5-day half-life keeps levels up.
Why one missed week isn't a disaster
Here's the reassuring pharmacology. Tirzepatide has an elimination half-life of about 5 days, and steady-state levels build over roughly the first 4 weeks of weekly dosing2. Because the drug is long-acting and lingers, the medicine from last week's injection is still substantially present when this week's dose is due. A single late or skipped dose causes only a gentle dip in your levels, not a sudden cliff.
That's very different from a fast-acting daily medication, where a missed dose leaves a same-day gap. With a once-weekly, slow-clearing drug, missing one shot — and correctly skipping it if you're past the 4-day window — has a modest, temporary effect. The trials that produced tirzepatide's large results were built on consistent weekly dosing over many months5, so the goal is steady adherence over time, not panic over a single lapse.
The flip side: don't make missed doses a habit
The flip side of "one miss is fine" is that the pattern matters. The pivotal weight-loss results came from people who stayed on therapy, and SURMOUNT-4 showed that stopping tirzepatide leads to substantial weight regain — people who came off after titrating up regained much of what they'd lost, while those who continued kept the result6. Repeated missed doses drift toward that "stopping" scenario.
So treat the 4-day rule as a safety net for the occasional slip, not a routine. If you find yourself missing doses often, the practical fixes are mundane but effective:
- Set a recurring weekly reminder for your injection day — the drug's slow rhythm makes a missed shot easy to overlook.
- Anchor the shot to a habit you rarely skip (a weekly meal, a Sunday routine).
- Keep your pens visible and correctly stored so "I forgot where it was" never becomes the reason.
When to call your clinician
A single missed dose handled by the 4-day rule needs no phone call. But reach out to your prescriber or pharmacist if:
- You've missed several weeks in a row and aren't sure whether to resume at your current dose or step back down — long gaps can reduce your tolerance to the dose, and your clinician may want to re-titrate.
- You accidentally took a double dose and develop severe or persistent nausea, vomiting, or dehydration — these are the dose-dependent GI effects the spacing rules exist to prevent3.
- You're unsure which strength pen you should be on after a gap.
When in doubt, the label and your care team beat any general rule of thumb.
The honest bottom line
Missed a tirzepatide dose? The FDA rule is simple: take it within 4 days (96 hours); if more than 4 days have passed, skip it and resume your normal weekly schedule — and never take two doses to catch up1. If a late dose shifts your day, you can change your weekly day as long as 72 hours separate two doses1. Because tirzepatide is long-acting (a ~5-day half-life), one missed week causes only a small dip, not a crisis2 — but consistent dosing is what drives and holds results56. For the full schedule, see the tirzepatide dosage chart; for injection technique, how and where to inject Zepbound; for the broader evidence, the tirzepatide evidence guide; and to weigh how to get it, our best tirzepatide overview.
Frequently asked questions
What should I do if I miss a tirzepatide dose?
Per the FDA label, take the missed dose as soon as possible within 4 days (96 hours) of when it was due, then continue your normal weekly schedule. If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Never take two doses to catch up.
Can I take two tirzepatide doses to make up for a missed one?
No. The label's rule is to take the single missed dose within the 4-day window or skip it — never to add it on top of your next scheduled dose. Doubling up spikes your drug exposure and can trigger severe nausea, vomiting, and diarrhea, which is exactly what the minimum 72-hour spacing between doses is designed to prevent.
How late can I take my tirzepatide injection?
Up to 4 days (96 hours) late. Within that window, take it as soon as you remember. Beyond 4 days, skip it and resume your normal weekly schedule. If taking a late dose shifts your day, you can change your weekly injection day as long as at least 72 hours separate the two doses.
Will one missed dose ruin my progress?
No. Tirzepatide is long-acting, with an elimination half-life of about 5 days, so the medicine from your last shot is still largely present when the next is due. One missed week causes only a small, temporary dip — not a cliff. Consistent dosing over months is what drives results, so an occasional miss handled by the 4-day rule is not a setback.
What if I've missed tirzepatide for several weeks?
Call your prescriber or pharmacist. After a long gap your tolerance to your current dose may drop, and your clinician may want to restart at a lower dose and re-titrate up to avoid a flare of gastrointestinal side effects. Don't simply resume your highest dose after weeks off without checking.
References(6)
- Eli Lilly and Company (FDA prescribing information via DailyMed) (2026). ZEPBOUND (tirzepatide) injection, for subcutaneous use — Prescribing Information & Instructions for Use (Dosage and Administration: Missed Dose; Important Administration Instructions).. DailyMed (U.S. National Library of Medicine), SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Eli Lilly and Company (FDA prescribing information via DailyMed) (2025). MOUNJARO (tirzepatide) injection, for subcutaneous use — Prescribing Information (Dosage and Administration; Clinical Pharmacology 12.3: half-life ~5 days; steady state by 4 weeks).. DailyMed (U.S. National Library of Medicine), SetID d2d7da5d-ad07-4228-955f-cf7e355c8cc0. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- Lin F, Yu B, Ling B, Lv G, Shang H, Zhao X, Jie X, Chen J, Li Y (2023). Weight loss efficiency and safety of tirzepatide: A Systematic review.. PLoS One. PMID: 37141329. https://pubmed.ncbi.nlm.nih.gov/37141329/
- Qin W, Yang J, Ni Y, Deng C, Ruan Q, Ruan J, Zhou P, Duan K (2024). Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis including the latest SURMOUNT-2 trial.. Endocrine. PMID: 38850440. https://pubmed.ncbi.nlm.nih.gov/38850440/
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA, and the SURMOUNT-4 Investigators (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.. JAMA. PMID: 38078870. https://pubmed.ncbi.nlm.nih.gov/38078870/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related monograph sections
Tirzepatide: Evidence, Dosing & Side Effects
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
ReadTirzepatide vs Semaglutide: Head-to-Head
How tirzepatide and semaglutide compare in the trials that put them head-to-head — SURPASS-2 for glucose, SURMOUNT-5 for weight loss. The honest verdict.
ReadTirzepatide Dosing Ladder & Side Effects
The tirzepatide titration schedule from the FDA label, why the dose climbs slowly, the common GI side effects, and practical ways to manage tolerability.
ReadWhat Happens If You Stop Tirzepatide?
What the SURMOUNT-4 trial shows about weight regain after stopping tirzepatide, and why it is an ongoing therapy rather than a short course.
ReadZepbound Side Effects: Full Breakdown by Frequency
Every Zepbound (tirzepatide) side effect from the FDA label, ranked by frequency — plus the gallbladder, pancreatitis, and thyroid warnings explained.
ReadZepbound for Sleep Apnea: The New FDA Indication
In Dec 2024 the FDA approved Zepbound for moderate-to-severe OSA in adults with obesity. What SURMOUNT-OSA showed, and why it's an adjunct, not a CPAP cure.
ReadHow & Where to Inject Zepbound: Step-by-Step (Pen & Vial)
A label-sourced walkthrough of injecting Zepbound (tirzepatide) — the pen, the vial, where to inject, site rotation, timing, storage, and sharps disposal.
ReadRetatrutide vs Tirzepatide: The Next-Gen Triple Agonist
Retatrutide's Phase 2 weight-loss numbers beat tirzepatide's — but it is still investigational and not FDA-approved. An honest, evidence-based comparison.
ReadHow Long Do Zepbound Side Effects Last?
Most Zepbound side effects are tied to dose increases and ease within days to a couple of weeks. Here is the honest timeline — and what doesn't follow it.
ReadDoes Zepbound Cause Hair Loss?
Zepbound's label lists hair loss in about 4-5% of users. The honest answer: it is almost certainly weight-loss shedding, not the drug attacking follicles.
ReadZepbound and Alcohol: What to Know
Zepbound has no labeled alcohol warning, but the honest answer is nuanced: overlapping GI effects, hypoglycemia and pancreatitis risk, and a craving signal.
ReadTirzepatide Dosage Chart: Full Titration Schedule
The complete tirzepatide titration chart from the FDA Zepbound and Mounjaro labels — every dose, every step, week by week, with the rules behind each.
ReadHow Many Units Is 2.5 mg of Tirzepatide?
There is no single unit answer for 2.5 mg of tirzepatide — it depends entirely on the compounded vial's concentration. Here's the math, and why it's risky.
ReadWhat Dose of Zepbound Is Most Effective?
Zepbound weight loss climbs with dose — 15 mg lost the most in SURMOUNT-1. But the most effective dose isn't always the highest one you can take.
ReadZepbound Cost, Coupons & the Cheapest Ways to Get It (2026)
List price, LillyDirect self-pay vials, the savings card, GoodRx-style coupons and compounded options — an honest, dated breakdown of what Zepbound costs.
ReadDoes Insurance Cover Zepbound? (Aetna, Medicare, BCBS & More) — 2026
Whether Aetna, BCBS, Cigna or Medicare cover Zepbound, why obesity-drug exclusions and prior auth block it, and how to appeal — an honest, dated guide.
ReadZepbound Results: How Much Weight Can You Lose (and How Fast)?
Trial-grounded Zepbound results: average weight loss by dose and week from SURMOUNT-1, why it takes months not weeks, and how regain works.
ReadZepbound Maintenance Dose After Goal Weight: What the Evidence Says
There's no single Zepbound maintenance dose. SURMOUNT-4 shows weight returns when you stop, so most people stay on an effective dose long term.
ReadZepbound Reviews: What Real Users (and the Trials) Report
An honest synthesis of what Zepbound reviews commonly say — efficacy, GI side effects, injection ease — set against the SURMOUNT trial data and FDA label.
ReadOral Tirzepatide: Is There a Pill? (Tablets & the Pipeline)
There is no FDA-approved oral tirzepatide — it is injectable-only. The oral GLP-1 pill in the pipeline is orforglipron, a different drug. An honest guide.
ReadSaxenda vs Zepbound: How They Compare
Saxenda (daily liraglutide) vs Zepbound (weekly tirzepatide): mechanism, average weight loss across trials, dosing, side effects, and cost, honestly compared.
ReadTirzepatide Constipation: Why It Happens and How to Get Relief
Constipation hits 11–17% of tirzepatide users in the FDA label. Here is why it happens, what eases it, and the red flags that mean call a clinician.
ReadDoes Tirzepatide Make You Tired? The Honest Answer
Fatigue is a modest tirzepatide side effect (about 5–7% vs 3% placebo). Here is why it usually happens — and the practical, mostly-secondary fixes.
ReadTirzepatide Sulfur Burps: Why They Happen and How to Stop Them
Rotten-egg sulfur burps are a common but anecdotal tirzepatide complaint, not a trial side effect. Here is the likely mechanism and what actually helps.
ReadTirzepatide and Acid Reflux/Heartburn: Why It Happens and What Helps
Tirzepatide can worsen acid reflux and heartburn in a dose-linked minority. Here is the mechanism, what the evidence shows, and the steps that actually ease it.
ReadDoes Tirzepatide Cause Muscle Loss?
In SURMOUNT-1, ~25% of weight lost on tirzepatide was lean mass — the same as placebo. What that means, and how protein and resistance training protect muscle.
ReadWhat to Eat on Tirzepatide (and Foods to Avoid)
An evidence-grounded food guide for tirzepatide: prioritize protein, fiber, and fluids; limit greasy, fried, sugary, and carbonated foods that worsen nausea.
ReadHow Much Protein on Tirzepatide for Muscle
To protect muscle on tirzepatide, aim for ~1.2–1.6 g of protein per kg daily (≈75–130 g), spread across meals, paired with resistance training.
ReadTirzepatide Weight-Loss Plateau: Why It Happens and What to Do
A tirzepatide plateau — under ~1% change over 4–6 weeks — is usually normal metabolic adaptation, not failure. Why it happens and the evidence-based responses.
ReadZepbound, Birth Control, and Pregnancy: What the Label Says
Zepbound's FDA label warns oral birth control can be less effective — use a non-oral method or backup for 4 weeks after starting and after each dose increase.
ReadStopping Tirzepatide Before Surgery and Anesthesia
Why tirzepatide is often paused before surgery for aspiration risk, what the FDA label and anesthesia guidance say, and how long to hold it.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
ReadMounjaro vs Zepbound: Same Drug, Different Approvals
Mounjaro and Zepbound are the identical tirzepatide molecule. What differs is the FDA indication, insurance coverage, and packaging — not the potency.
ReadSwitching From Semaglutide to Tirzepatide
There is no 1:1 dose conversion. You restart tirzepatide at 2.5 mg regardless of your prior semaglutide dose — and the GI side effects re-titrate. Here's why.
ReadTirzepatide Storage: How Long Out of the Fridge?
Per the FDA label, an unopened tirzepatide pen or vial can sit at room temperature (≤86°F) for up to 21 days. Never refreeze it. The exact rules, quoted.
ReadTirzepatide and Vision Loss (NAION): What the Evidence Actually Shows
A rare optic-nerve stroke (NAION) is linked to GLP-1 drugs. The signal is strongest for semaglutide; tirzepatide-specific evidence is thin and not on the label.
ReadTirzepatide Injection-Site Reactions: Lumps, Itching, and Redness
Lumps, itching, and redness where you inject tirzepatide are usually mild and self-limiting. Why they happen, how to ease them, and the escalation signs.
ReadTirzepatide Diarrhea: Why It Happens and When to Worry
Diarrhea hits about 19–23% of tirzepatide users on the FDA label. Why it happens, when it settles, and the dehydration red flags that mean call a clinician.
ReadTirzepatide and Your Kidneys: AKI Risk, Explained Honestly
Tirzepatide isn't toxic to the kidneys — and may protect them. The real risk is indirect acute kidney injury from dehydration. What the label and trials show.
ReadTirzepatide and Pancreatitis: How Real Is the Risk?
Pancreatitis on tirzepatide is rare (~0.2–0.4% in trials, not above comparators) but FDA-label-warned. The radiating back-pain red flag and what to do.
ReadTirzepatide for PCOS, Fertility & 'Ozempic Babies'
Tirzepatide isn't FDA-approved for PCOS, but weight loss can restore ovulation — raising real unplanned-pregnancy risk. Why it's contraindicated in pregnancy.
ReadTirzepatide and Pregnancy: What the Label and the Evidence Say
Tirzepatide (Zepbound, Mounjaro) is not for use in pregnancy: the FDA label says stop it when pregnancy is recognized. Here is the guidance and the human data.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadFoods to Avoid on Tirzepatide (and Why They Trigger Symptoms)
High-fat, fried, sugary, carbonated, and alcoholic foods compound tirzepatide's delayed gastric emptying — here's what to limit and the mechanism behind each.
ReadBest Time & Day to Inject Tirzepatide: What the Label Says
The FDA label allows tirzepatide at any time of day, with or without food. Why timing barely affects results — and the one switching-day rule that matters.
ReadOrforglipron (Foundayo): The First Oral Non-Peptide GLP-1, Explained
Orforglipron is a once-daily oral GLP-1 pill, FDA-approved as Foundayo. The ATTAIN/ACHIEVE trial data, side effects, and how it compares to tirzepatide.
Read